
  
    
      
        Background_NNP
        Fetal_NNP alcohol_NN syndrome_NN (_( FAS_NNP )_) children_NNS do_VBP not_RB display_VB the_DT
        normal_JJ hemispheric_JJ dominance_NN patterns_NNS observed_VBD in_IN non-_NN FAS_NNP
        children_NNS [_NN 1_CD ]_NN ._. Dominance_NNP has_VBZ been_VBN disrupted_VBN or_CC is_VBZ ,_, in_IN
        some_DT cases_NNS ,_, completely_RB absent_JJ ,_, depending_VBG on_IN the_DT amount_NN of_IN
        tissue_NN loss_NN in_IN the_DT corpus_NN callosum_NN ._. Morphological_NNP
        abnormalities_NNS ,_, one_CD of_IN which_WDT is_VBZ corpus_NN callosum_NN hypoplasia_NN ,_,
        has_VBZ been_VBN observed_VBN in_IN children_NNS with_IN FAS_NNP [_NN 2_CD ]_NN ._. Archibald_NNP et_CC
        al_NN ._. [_NN 3_CD ]_NN ,_, using_VBG structural_JJ magnetic_JJ imaging_NN (_( sMRI_NN )_) ,_, also_RB
        noted_VBD that_IN there_EX were_VBD corpus_NN callosum_NN abnormalities_NNS in_IN
        children_NNS who_WP had_VBD experienced_VBN prenatal_NN exposure_NN to_TO ethanol_NN ._.
        In_IN a_DT magnetic_JJ resonance_NN imaging_NN (_( MRI_NNP )_) study_NN of_IN adult_NN FAS_NNP
        males_NNS ,_, callosal_NN morphological_JJ data_NNS ,_, when_WRB compared_VBN with_IN
        landmark_NN data_NNS ,_, differed_VBD significantly_RB from_IN that_DT of_IN control_NN
        males_NNS [_NN 4_CD ]_NN ._.
        Agenesis_NNP of_IN the_DT corpus_NN callosum_NN occurs_VBZ as_IN a_DT consequence_NN
        of_IN early_JJ embryonic_JJ insult_NN ._. The_DT exact_JJ time_NN of_IN the_DT insult_NN
        usually_RB determines_VBZ the_DT extent_NN of_IN commissural_NN agenesis_NNS ._.
        Jeeves_NNP et_CC al_NN ._. [_NN 5_CD ]_NN reported_VBD a_DT timetable_NN in_IN which_WDT ,_, if_IN the_DT
        insult_NN occurs_VBZ before_IN the_DT tenth_NN embryonic_JJ week_NN (_( in_IN humans_NNS )_) ,_,
        all_DT forebrain_NN commissures_NNS will_MD be_VB absent_JJ ._. Miller_NNP [_NN 6_CD ]_NN
        observed_VBD that_IN in_IN utero_NN exposure_NN to_TO ethanol_NN (_( EtOH_NNP )_) disrupted_VBD
        the_DT distribution_NN of_IN callosal_NN projection_NN neurons_NNS in_IN the_DT rat_NN
        somatosensory_NN cortex_NN ._. The_DT complete_JJ absence_NN of_IN a_DT corpus_NN
        callosum_NN in_IN rats_NNS exposed_VBN in_IN utero_NN to_TO EtOH_NNP has_VBZ been_VBN
        documented_VBN by_IN several_JJ studies_NNS [_NN 7_CD 8_CD 9_CD ]_NN ._. Because_IN in_IN utero_NN
        exposure_NN to_TO EtOH_NNP affects_VBZ both_DT corpus_NN callosum_NN development_NN
        and_CC laterality_NN ,_, researchers_NNS have_VBP turned_VBN to_TO the_DT rat_NN model_NN to_TO
        assess_VB the_DT impact_NN of_IN EtOH_NNP on_IN both_DT measures_NNS ._.
        In_IN Zimmerberg_NNP et_CC al_NN ._. [_NN 10_CD ]_NN rats_NNS prenatally_RB exposed_VBN to_TO a_DT
        35_CD %_NN ethanol_NN derived_VBD calories_NNS (_( EDC_NNP )_) liquid_JJ diet_NN did_VBD not_RB
        display_VB a_DT preferred_JJ side_NN for_IN the_DT 2_CD -_: hole_NN nose-poke_JJ
        apparatus_NN ,_, unlike_IN rats_NNS whose_WP$ mothers_NNS were_VBD maintained_VBN on_IN a_DT
        chow_NN or_CC liquid_JJ diet_NN ._. Later_RB ,_, Zimmerberg_NNP et_CC al_NN ._. [_NN 1_CD ]_NN
        assessed_VBD laterality_NN using_VBG a_DT left_VBN /_NN right_JJ lever_NN choice_NN on_IN a_DT
        continuous_JJ reinforcement_NN schedule_NN ._. Again_RB the_DT rats_NNS exposed_VBN
        in_IN utero_NN to_TO EtOH_NNP displayed_VBD less_JJR side_NN preference_NN than_IN the_DT
        chow_NN fed_VBN and_CC liquid_JJ diet_NN pairfed_JJ rats_NNS ._. When_WRB London_NNP [_NN 11_CD ]_NN
        tested_VBD paw_NN preference_NN in_IN rats_NNS ,_, he_PRP found_VBD that_IN rats_NNS exposed_VBN
        to_TO ethanol_NN during_IN gestation_NN were_VBD more_RBR likely_JJ than_IN control_NN
        rats_NNS to_TO preferentially_RB use_VB the_DT left_NN paw_NN ._. In_IN 1989_CD ,_,
        Zimmerberg_NNP et_CC al_NN ._. [_NN 12_CD ]_NN tested_VBD preferred_VBN tail_NN direction_NN in_IN
        neonates_NNS exposed_VBN in_IN utero_NN to_TO EtOH_NNP ._. When_WRB compared_VBN to_TO the_DT 0_CD %_NN
        EDC_NNP group_NN and_CC the_DT chow_NN group_NN ,_, a_DT left-preferred_JJ tail_NN
        direction_NN was_VBD exhibited_VBN by_IN rats_NNS from_IN the_DT 35_CD %_NN EDC_NNP group_NN ._.
        Thus_RB it_PRP appears_VBZ that_IN in_IN utero_NN exposure_NN to_TO ethanol_NN ,_, at_IN least_JJS
        in_IN rats_NNS ,_, results_NNS in_IN a_DT disruption_NN of_IN laterality_NN
        patterns_NNS ._.
        We_PRP have_VBP investigated_VBN the_DT potential_JJ fetoprotective_JJ
        capacity_NN of_IN silymarin_NN (_( SY_NNP )_) against_IN the_DT toxic_JJ effects_NNS of_IN in_IN
        utero_NN exposure_NN to_TO ethanol_NN ._. Silymarin_NNP has_VBZ long_RB been_VBN noted_VBN
        for_IN its_PRP$ hepatoprotective_JJ properties_NNS [_NN 13_CD ]_NN ._. The_DT mechanisms_NNS
        through_IN which_WDT SY_NNP is_VBZ thought_VBN to_TO manifest_JJ its_PRP$ therapeutic_JJ
        effects_NNS include_VBP the_DT following_VBG :_: 1_LS )_) enhanced_JJ protein_NN
        synthesis_NN [_NN 14_CD ]_NN ,_, 2_LS )_) scavenging_VBG free_JJ radicals_NNS [_NN 15_CD ]_NN ,_, 3_LS )_)
        prevention_NN of_IN glutathione_NN (_( GSH_NNP )_) depletion_NN [_NN 16_CD ]_NN ,_, and_CC 4_LS )_)
        preservation_NN of_IN cell_NN membrane_NN integrity_NN [_NN 17_CD ]_NN ._. The_DT
        theories_NNS formulated_VBN to_TO explain_VB the_DT physiological_JJ events_NNS
        that_WDT culminate_NN in_IN fetal_JJ alcohol_NN syndrome_NN include_VBP decreased_VBN
        antioxidant_NN levels_NNS ,_, decreased_VBD protein_NN synthesis_NN ,_, increased_VBD
        free_JJ radical_JJ activity_NN ,_, and_CC disrupted_VBD membrane_NN function_NN ._. The_DT
        observation_NN that_IN the_DT protective_JJ effects_NNS of_IN SY_NNP and_CC the_DT
        causal_NN factors_NNS in_IN FAS_NNP overlap_VB ,_, led_VBN us_PRP to_TO investigate_VB the_DT
        possibility_NN that_IN SY_NNP might_MD have_VB application_NN as_IN a_DT
        fetoprotectant_NN compound_NN ._. In_IN a_DT series_NN of_IN studies_NNS conducted_VBN
        in_IN our_PRP$ lab_NN we_PRP have_VBP demonstrated_VBN that_IN the_DT coadministration_NN
        of_IN SY_NNP with_IN ethanol_NN prevents_VBZ ethanol-induced_JJ decreases_NNS in_IN
        neonate_NN mortality_NN rate_NN ,_, decreases_NNS in_IN pup_NN birth_NN weight_NN ,_, and_CC
        increases_NNS in_IN liver_NN and_CC brain_NN gamma_NN glutamyl_NN transpeptidase_NN
        (_( GGTP_NNP )_) activity_NN [_NN 18_CD 19_CD ]_NN ._. SY_NNP also_RB prevented_VBD the_DT deficits_NNS
        in_IN spatial_NN memory_NN and_CC social_JJ memory_NN observed_VBD in_IN rats_NNS
        exposed_VBN in_IN utero_NN to_TO EtOH_NNP [_NN 20_CD 21_CD ]_NN ._.
        Given_VBN that_IN SY_NNP has_VBZ been_VBN successful_JJ in_IN ameliorating_VBG some_DT
        of_IN the_DT negative_JJ consequences_NNS of_IN in_IN utero_NN exposure_NN to_TO EtOH_NNP
        (_( in_IN the_DT rat_NN model_NN )_) ,_, we_PRP examined_VBD the_DT possibility_NN that_IN SY_NNP
        might_MD prevent_VB EtOH-induced_NNP callosal_NN agenesis_NNS and_CC the_DT
        disruption_NN of_IN laterality_NN (_( as_IN measured_VBN by_IN paw_NN
        preference_NN )_) ._.
      
      
        Methods_NNP
        
          Subjects_NNP
          Subjects_NNP were_VBD 50_CD female_JJ Fisher_NNP /_NN 344_CD rats_NNS weighing_VBG
          235_CD -_: 245_CD g_SYM ._. The_DT females_NNS were_VBD housed_VBN with_IN male_JJ rats_NNS until_IN
          pregnancy_NN was_VBD confirmed_VBN by_IN vaginal_JJ smear_NN ._. Once_RB pregnancy_NN
          was_VBD confirmed_VBN ,_, the_DT rats_NNS were_VBD placed_VBN in_IN standard_JJ plastic_NN
          laboratory_NN maternal_NN tubs_NNS and_CC assigned_VBN to_TO one_CD of_IN five_CD
          gestational_JJ treatment_NN groups_NNS ._. Ten_CD pregnant_JJ females_NNS were_VBD
          assigned_VBN to_TO each_DT treatment_NN group_NN ._. Group_NNP 1_CD consisted_VBD of_IN
          pregnant_JJ females_NNS that_WDT received_VBD the_DT liquid_JJ diet_NN regimen_NN
          (_( Bioserve_NNP ;_: Frenchtown_NNP ,_, NJ_NNP )_) containing_VBG an_DT isocaloric_JJ
          amount_NN of_IN dextrin_NN maltose_NN that_WDT matched_VBD the_DT caloric_JJ amount_NN
          in_IN the_DT EtOH_NNP diet_NN ._. Group_NNP 2_CD rats_NNS were_VBD provided_VBN with_IN the_DT
          liquid_JJ diet_NN to_TO which_WDT a_DT 400_CD -_: mg_NN /_NN kg_NN dose_NN of_IN silymarin_NN (_( SY_NNP )_)
          was_VBD added_VBN ._. The_DT SY_NNP ,_, provided_VBN by_IN Inverni_NNP della_NN Beffa_NNP ,_,
          Milano_NNP ,_, Italy_NNP ,_, contained_VBD 29_CD ._. 8_CD %_NN silybin_NN complexed_JJ with_IN
          phosphatidylcholine_NN ._. The_DT dose_NN administered_VBN to_TO the_DT rats_NNS
          was_VBD based_VBN on_IN the_DT percent_NN active_JJ ingredient_NN in_IN the_DT
          compound_NN and_CC was_VBD derived_VBN from_IN data_NNS acquired_VBN in_IN our_PRP$
          previous_JJ studies_NNS [_NN 18_CD 19_CD ]_NN ._. Group_NNP 3_CD rats_NNS received_VBD the_DT
          liquid_JJ diet_NN ,_, which_WDT contained_VBD both_DT the_DT SY_NNP and_CC 35_CD %_NN
          ethanol-derived_JJ calories_NNS (_( 6_CD ._. 7_CD %_NN EtOH_NNP solution_NN )_) ._. In_IN
          previous_JJ studies_NNS we_PRP established_VBD blood_NN alcohol_NN
          concentrations_NNS (_( BACs_NNP )_) for_IN all_DT experimental_JJ groups_NNS and_CC
          ascertained_JJ that_IN SY_NNP does_VBZ not_RB have_VB any_DT appreciable_JJ affect_NN
          on_IN BAC_NNP [_NN 21_CD ]_NN ._. The_DT rats_NNS in_IN Group_NNP 4_CD were_VBD maintained_VBN on_IN
          the_DT 35_CD %_NN EDC_NNP liquid_JJ diet_NN and_CC Group_NNP 5_CD rats_NNS were_VBD provided_VBN
          with_IN unlimited_JJ access_NN to_TO Purina_NNP lab_NN chow_NN ._. The_DT amount_NN of_IN
          liquid_JJ diet_NN provided_VBN to_TO the_DT rats_NNS in_IN Groups_NNS 1_CD ,_, 2_CD ,_, and_CC 3_CD
          was_VBD determined_VBN by_IN the_DT amount_NN of_IN liquid_JJ diet_NN consumed_VBD the_DT
          preceding_VBG day_NN by_IN the_DT rats_NNS in_IN Group_NNP 4_CD ._. The_DT liquid_JJ diet_NN
          treatments_NNS were_VBD discontinued_VBN five_CD days_NNS before_IN the_DT dams_NNS
          gave_VBD birth_NN at_IN which_WDT time_NN they_PRP were_VBD provided_VBN access_NN to_TO
          Purina_NNP lab_NN chow_NN ._. When_WRB the_DT EtOH_NNP administration_NN is_VBZ
          continued_VBN until_IN birth_NN ,_, pup_NN survival_NN rats_NNS are_VBP extremely_RB
          low_JJ ._. Once_RB pups_NNS reached_VBD age_NN 18_CD -_: 21_CD days_NNS they_PRP were_VBD weaned_JJ
          and_CC placed_VBN in_IN individual_JJ standard_JJ laboratory_NN cages_NNS ._. On_IN
          the_DT day_NN of_IN weaning_VBG we_PRP randomly_RB selected_VBD one_CD female_JJ pup_NN
          from_IN each_DT litter_NN and_CC as_IN subjects_NNS in_IN the_DT laterality_NN
          testing_NN procedure_NN ._. We_PRP used_VBD females_NNS in_IN an_DT effort_NN to_TO remedy_VB
          the_DT paucity_NN of_IN FAS-related_NNP data_NNS collected_VBN on_IN female_JJ
          rodents_NNS ._. A_DT total_NN of_IN 10_CD female_JJ rat_NN pups_NNS were_VBD selected_VBN from_IN
          each_DT of_IN the_DT five_CD original_JJ treatment_NN groups_NNS ._.
        
        
          Apparatus_NNP and_CC procedures_NNS
          
            Testing_NNP apparatus_NN for_IN laterality_NN
            All_DT testing_NN sessions_NNS took_VBD place_NN in_IN a_DT reaching_VBG
            apparatus_NN ._. The_DT apparatus_NN was_VBD made_VBN up_RP of_IN three_CD
            contiguous_JJ plastic_NN cubicles_NNS ,_, each_DT of_IN which_WDT measured_VBD
            24_CD ._. 13_CD cm_NN ×_NN 7_CD ._. 62_CD cm_NN ×_NN 16_CD ._. 41_CD cm_NN ._. The_DT adjoining_JJ walls_NNS of_IN
            the_DT cubicle_NN were_VBD 6_CD ._. 35_CD mm_NN thick_JJ and_CC were_VBD painted_VBN white_JJ
            so_IN that_IN rats_NNS in_IN adjacent_JJ cubicles_NNS could_MD not_RB see_VB each_DT
            other_JJ ._. An_DT 11_CD mm_NN tube_NN was_VBD installed_VBN in_IN the_DT face_NN of_IN each_DT
            cubicle_NN ._. All_DT test_NN sessions_NNS were_VBD videotaped_JJ ._.
          
          
            Laterality_NNP testing_NN procedure_NN
            The_DT rats_NNS began_VBD laterality_NN testing_NN at_IN age_NN 12_CD weeks_NNS ._.
            They_PRP were_VBD food-deprived_JJ for_IN 14_CD -_: 21_CD hr_NN prior_RB to_TO the_DT
            testing_NN sessions_NNS and_CC each_DT rat_NN participated_VBD in_IN three_CD
            testing_NN sessions_NNS ._. They_PRP were_VBD placed_VBN three_CD at_IN a_DT time_NN into_IN
            the_DT reaching_VBG apparatus_NN ,_, one_CD in_IN each_DT cubicle_NN ._. Rats_NNP
            remained_VBD in_IN the_DT reaching_VBG apparatus_NN until_IN they_PRP had_VBD
            either_CC reached_VBN 50_CD times_NNS for_IN food_NN (_( Fruit_NNP Loops_NNP )_) or_CC one_CD
            hour_NN had_VBD passed_VBN ._. A_DT single_JJ Fruit_NNP Loop_NNP was_VBD placed_VBN in_IN the_DT
            reaching_VBG tube_NN for_IN each_DT trial_NN ._. A_DT successful_JJ reach_NN was_VBD
            defined_VBN as_IN the_DT rat_NN obtaining_VBG the_DT piece_NN of_IN Fruit_NNP Loop_NNP ._.
            Each_DT time_NN the_DT Fruit_NNP Loop_NNP was_VBD retrieved_VBN another_DT piece_NN
            was_VBD immediately_RB placed_VBN into_IN the_DT tube_NN ._. Upon_IN completion_NN
            of_IN a_DT testing_VBG session_NN rats_NNS were_VBD taken_VBN out_IN of_IN the_DT
            reaching_VBG apparatus_NN and_CC placed_VBN back_RB into_IN their_PRP$ cage_NN ._.
          
          
            Perfusion_NNP
            After_IN all_DT of_IN the_DT rats_NNS had_VBD completed_VBN the_DT reaching_VBG
            protocol_NN they_PRP were_VBD anesthetized_JJ and_CC intracardially_RB
            injected_VBN first_JJ with_IN Ringers_NNS solution_NN and_CC then_RB with_IN a_DT
            fixing_VBG solution_NN ._. After_IN sacrifice_NN the_DT brains_NNS were_VBD
            removed_VBN ,_, preserved_VBN in_IN formalin_NN ,_, and_CC stored_VBD in_IN a_DT
            refrigerator_NN for_IN later_RB corpus_NN callosum_NN extraction_NN ._.
          
          
            Corpus_NNP callosum_NN extraction_NN
            Because_IN hemisphere_NN weights_NNS were_VBD also_RB dependent_JJ
            variables_NNS a_DT cut_NN was_VBD made_VBN through_IN the_DT longitudinal_NN
            fissure_NN that_IN separated_JJ the_DT two_CD hemispheres_NNS ,_, which_WDT then_RB
            exposed_VBD the_DT two_CD halves_NNS of_IN the_DT corpus_NN callosum_NN ._. The_DT
            hemispheres_NNS were_VBD weighed_VBN separately_RB prior_RB to_TO corpus_NN
            callosum_NN extraction_NN ._. Using_VBG a_DT surgical_JJ knife_NN the_DT corpus_NN
            callosum_NN was_VBD outlined_VBN and_CC lifted_VBN away_RB from_IN the_DT rest_NN of_IN
            the_DT brain_NN ._. The_DT two_CD halves_NNS of_IN the_DT corpus_NN callosum_NN were_VBD
            weighed_VBN separately_RB on_IN an_DT analytical_JJ balance_NN ._. The_DT total_JJ
            length_NN of_IN the_DT corpus_NN callosum_NN was_VBD measured_VBN before_IN and_CC
            after_IN extraction_NN ._. The_DT genu_NN ,_, body_NN ,_, and_CC splenium_NN were_VBD
            identified_VBN to_TO confirm_VB complete_JJ development_NN of_IN the_DT
            corpus_NN callosum_NN ._.
          
        
        
          Statistics_NNS
          The_DT criterion_NN for_IN assessing_VBG individual_JJ laterality_NN was_VBD
          generated_VBN from_IN binomial_NN z_SYM scores_NNS ._. To_TO identify_VB a_DT group_NN of_IN
          rats_NNS as_IN demonstrating_VBG paw_NN preference_NN ,_, 7_CD of_IN 10_CD rats_NNS had_VBD to_TO
          be_VB observed_VBN reaching_VBG in_IN the_DT same_JJ direction_NN ._. Three_CD raters_NNS ,_,
          who_WP were_VBD unaware_JJ of_IN treatment_NN groupings_NNS ,_, observed_VBD and_CC
          counted_VBD the_DT reaches_NNS ._. The_DT Statistical_NNP Package_NNP for_IN Social_NNP
          Sciences_NNPS (_( SPSS_NNP )_) Reliability_NNP Analysis_NNP was_VBD used_VBN for_IN
          inter-rater_JJ reliability_NN ._. A_DT priori_FW contrasts_VBZ were_VBD
          conducted_VBN to_TO determine_VB if_IN differences_NNS existed_VBD between_IN
          groups_NNS on_IN all_DT dependent_JJ measures_NNS (_( laterality_NN ,_, corpus_NN
          callosum_NN [_NN development_NN and_CC weight_NN ]_NN ,_, splenium_NN development_NN ,_,
          total_JJ brain_NN weight_NN ,_, and_CC pup_NN weight_NN gain_NN )_) ._.
        
      
      
        Results_NNS
        Pup_NNP weights_NNS were_VBD recorded_VBN at_IN birth_NN and_CC again_RB when_WRB the_DT
        rats_NNS were_VBD weaned_JJ ._. An_DT ANOVA_NNP and_CC subsequent_JJ post_NN hoc_FW Tukey_NNP
        comparisons_NNS revealed_VBD that_IN there_EX were_VBD no_DT significant_JJ birth_NN
        weight_NN differences_NNS for_IN any_DT experimental_JJ group_NN as_IN compared_VBN
        with_IN the_DT LD_NNP group_NN ;_: although_IN ,_, the_DT overall_JJ ANOVA_NNP was_VBD
        significant_JJ ,_, F_NN (_( 4_CD ,_, 45_CD )_) =_SYM 4_CD ._. 98_CD ,_, 
        p_NN <_NN ._. 05_CD )_) ._. However_RB ,_, when_WRB the_DT
        wean_VB weights_NNS were_VBD analyzed_VBN ,_, the_DT ANOVA_NNP results_NNS were_VBD
        significant_JJ ,_, F_NN (_( 4_CD ,_, 45_CD )_) =_SYM 6_CD ._. 77_CD ,_, p_NN <_NN ._. 01_CD and_CC ,_, the_DT posthoc_NN
        tests_NNS specified_VBN that_IN the_DT EtOH_NNP group_NN (_( 
        M_NNP =_SYM 43_CD ._. 12_CD g_SYM )_) differed_VBD
        significantly_RB from_IN the_DT LD_NNP group_NN (_( 
        M_NNP =_SYM 50_CD ._. 08_CD g_SYM )_) ,_, t_NN (_( 45_CD )_) =_SYM 4_CD ._. 476_CD ,_, 
        p_NN <_NN ._. 001_CD ._. This_DT indicates_VBZ that_IN
        the_DT EtOH_NNP pups_NNS gained_VBD comparatively_RB less_JJR weight_NN during_IN the_DT
        period_NN between_IN postnatal_NN day_NN (_( PND_NNP )_) 1_CD and_CC PND_NNP 20_CD ,_, which_WDT is_VBZ
        when_WRB the_DT pups_NNS were_VBD weaned_JJ ._. A_DT percent_NN weight_NN gain_NN was_VBD
        calculated_VBN for_IN each_DT group_NN (_( see_VB Table_NNP 1_LS )_) ._. Eta_NNP square_RB was_VBD
        calculated_VBN and_CC indicated_VBN that_IN 61_CD %_NN of_IN the_DT variance_NN in_IN pup_NN
        weight_NN gain_NN values_NNS was_VBD attributable_JJ to_TO the_DT treatment_NN
        received_VBD during_IN gestation_NN ._.
        Total_JJ brain_NN weight_NN and_CC corpus_NN callosum_NN weight_NN were_VBD
        determined_VBN for_IN each_DT of_IN the_DT pups_NNS and_CC a_DT total_JJ weight_NN to_TO
        corpus_NN callosum_NN ratio_NN calculated_VBN (_( see_VB Table_NNP 2_LS )_) ._. Eta_NNP square_RB
        was_VBD again_RB calculated_VBN for_IN the_DT variance_NN in_IN corpus_NN callosum_NN
        weight_NN resulting_VBG in_IN 56_CD %_NN of_IN the_DT variance_NN attributable_JJ to_TO the_DT
        treatment_NN condition_NN ._. After_IN perfusion_NN the_DT brains_NNS were_VBD
        visually_RB inspected_VBN to_TO determine_VB whether_IN or_CC not_RB the_DT splenium_NN
        was_VBD fully_RB developed_VBN ._. Of_IN the_DT 50_CD rats_NNS tested_VBN ,_, 8_CD did_VBD not_RB have_VB
        a_DT fully_RB developed_VBN splenium_NN ._. All_DT 8_CD rats_NNS were_VBD from_IN the_DT EtOH_NNP
        group_NN (_( see_VB Table_NNP 3_LS )_) ._. A_DT priori_FW contrasts_VBZ were_VBD conducted_VBN to_TO
        assess_VB group_NN differences_NNS ._. All_DT of_IN the_DT group_NN comparisons_NNS were_VBD
        made_VBN with_IN the_DT Liquid_NNP Diet_NNP (_( LD_NNP )_) group_NN ._. Significant_JJ
        differences_NNS are_VBP reported_VBN in_IN Tables_NNP 1_CD ,_, 2_CD ,_, 3_CD ._.
      
      
        Discussion_NNP
        EtOH_NNP had_VBD an_DT adverse_JJ impact_NN on_IN birth_NN weight_NN as_IN indicated_VBN
        in_IN Table_NNP 1_CD ._. Further_RB ,_, the_DT in_IN utero_NN exposure_NN to_TO EtOH_NNP also_RB
        prevented_VBD normal_JJ weight_NN gain_NN during_IN the_DT 20_CD -_: day_NN suckling_VBG
        period_NN ._. SY_NNP given_VBN in_IN combination_NN with_IN EtOH_NNP appeared_VBD to_TO
        prevent_VB the_DT EtOH-associated_NNP low_JJ birth_NN weight_NN and_CC attenuated_JJ
        weight_NN gain_NN ._. Although_IN the_DT birth_NN weight_NN of_IN the_DT SY-only_NNP pups_NNS
        was_VBD normal_JJ ,_, weight_NN gain_NN during_IN the_DT suckling_VBG period_NN was_VBD
        significantly_RB less_JJR than_IN that_DT of_IN the_DT LD_NNP group_NN ._. Weight_NNP gain_NN
        for_IN the_DT SY_NNP pups_NNS ,_, however_RB ,_, was_VBD still_RB more_JJR than_IN that_DT observed_VBD
        for_IN the_DT EtOH_NNP pups_NNS ._. In_IN a_DT previous_JJ study_NN [_NN 20_CD ]_NN SY_NNP pup_NN weight_NN
        gain_NN did_VBD not_RB differ_VB significantly_RB from_IN weight_NN gained_VBN by_IN LD_NNP
        pups_NNS ._.
        Brain_NNP weights_NNS did_VBD not_RB differ_VB significantly_RB ,_, although_IN the_DT
        lowest_JJS weights_NNS were_VBD observed_VBN in_IN the_DT EtOH_NNP ._. Corpus_NNP callosum_NN
        (_( CC_NNP )_) weights_NNS did_VBD vary_VB significantly_RB ,_, for_IN which_WDT the_DT EtOH_NNP
        pups_NNS had_VBD the_DT lowest_JJS weights_NNS ._. Inexplicably_RB ,_, the_DT Chow_NNP pup_NN
        callosal_NN data_NNS weight_NN data_NNS did_VBD not_RB differ_VB from_IN that_DT of_IN the_DT
        EtOH_NNP pups_NNS ._. However_RB ,_, when_WRB the_DT ratio_NN of_IN brain_NN weight_NN to_TO CC_NNP
        weight_NN was_VBD calculated_VBN there_EX were_VBD no_DT significant_JJ group_NN
        differences_NNS ._. The_DT EtOH_NNP group_NN brain_NN to_TO CC_NNP weight_NN ratio_NN
        indicated_VBD that_IN the_DT CC_NNP weight_NN as_IN compared_VBN to_TO total_VB brain_NN
        weight_NN was_VBD the_DT lowest_JJS observed_VBN among_IN all_DT of_IN the_DT treatment_NN
        groups_NNS ._. This_DT lower_JJR CC_NNP weight_NN might_MD be_VB associated_VBN with_IN the_DT
        unusual_JJ left_JJ paw_NN preference_NN displayed_VBN by_IN the_DT EtOH_NNP pups_NNS ._. As_IN
        an_DT indication_NN of_IN EtOH_NNP and_CC SY_NNP fetal_JJ effects_VBZ the_DT CC_NNP weight_NN
        measure_NN does_VBZ not_RB seem_VB to_TO provide_VB much_JJ relevant_JJ information_NN ,_,
        whereas_IN the_DT measure_NN of_IN splenium_NN development_NN clearly_RB
        indicates_VBZ EtOH-induced_NNP disruption_NN ._. The_DT in_IN utero_NN effect_NN of_IN
        EtOH_NNP on_IN splenium_NN development_NN has_VBZ also_RB been_VBN observed_VBN in_IN
        humans_NNS with_IN FAS_NNP ._. Sowell_NNP et_CC al_NN ._. [_NN 22_CD ]_NN ,_, using_VBG MRI_NNP analytic_JJ
        methods_NNS determined_VBN that_IN EtOH-related_NNP callosal_NN area_NN
        reductions_NNS were_VBD most_RBS severe_JJ in_IN the_DT splenium_NN ._.
        Consistent_NNP with_IN the_DT London_NNP [_NN 11_CD ]_NN investigation_NN ,_, the_DT
        EtOH-exposed_NNP rats_NNS displayed_VBD a_DT left_VBN paw_NN preference_NN ._. Further_RB
        evidence_NN of_IN laterality_NN disruption_NN was_VBD manifested_JJ by_IN
        incomplete_JJ splenium_NN development_NN in_IN 8_CD of_IN the_DT 10_CD EtOH-exposed_NNP
        rats_NNS ._. The_DT paw_NN preference_NN scores_NNS in_IN the_DT LD_NNP and_CC Chow_NNP groups_NNS
        indicated_VBD an_DT even_JJ distribution_NN between_IN left_VBD and_CC right_JJ paw_NN
        preference_NN ._. An_DT unexpected_JJ finding_NN was_VBD that_IN of_IN the_DT strong_JJ
        right_JJ paw_NN preference_NN displayed_VBN by_IN the_DT rats_NNS from_IN the_DT SY_NNP and_CC
        SY_NNP /_NN EtOH_NNP groups_NNS ._. Given_VBN the_DT 50_CD :_: 50_CD left_VBD /_NN right_JJ paw_NN preference_NN
        of_IN the_DT Chow_NNP and_CC LD_NNP groups_NNS ;_: the_DT expected_VBN outcome_NN of_IN SY_NNP
        influence_NN would_MD be_VB the_DT preservation_NN of_IN the_DT 50_CD :_: 50_CD ratio_NN ._. The_DT
        SY_NNP paw_NN preference_NN results_NNS are_VBP ,_, however_RB ,_, consistent_JJ with_IN a_DT
        very_RB recent_JJ study_NN by_IN Pence_NNP [_NN 23_CD ]_NN ._. Male_NN and_CC female_JJ rats_NNS
        were_VBD tested_VBN for_IN paw_NN preference_NN using_VBG a_DT food-reaching_JJ task_NN ._.
        There_EX was_VBD no_DT significant_JJ sex_NN difference_NN ._. He_PRP did_VBD observe_VB
        that_DT 70_CD ._. 2_LS %_NN of_IN the_DT rats_NNS were_VBD right_NN pawed_JJ ,_, 19_CD ._. 3_LS %_NN were_VBD left_VBN
        pawed_JJ ,_, and_CC 11_CD ._. 9_CD %_NN were_VBD ambidextrous_JJ ._. Our_PRP$ observations_NNS can_MD be_VB
        summarized_VBD as_IN follows_VBZ :_: 1_LS )_) Fisher_NNP /_NN 344_CD rats_NNS when_WRB not_RB subject_JJ
        to_TO any_DT form_NN of_IN prenatal_NN insult_NN and_CC subsequently_RB raised_VBD with_IN
        adequate_JJ nutrition_NN and_CC housing_NN do_VBP not_RB ,_, as_IN a_DT group_NN ,_, display_NN
        any_DT particular_JJ paw_NN preference_NN ._. 2_LS )_) Rats_NNP when_WRB exposed_VBN in_IN
        utero_NN to_TO EtOH_NNP experience_NN tissue_NN loss_NN in_IN the_DT splenium_NN and_CC ,_,
        as_IN a_DT group_NN ,_, display_NN a_DT left_VBN paw_NN preference_NN ._. 3_LS )_) Rats_NNP that_WDT
        have_VBP been_VBN exposed_VBN in_IN utero_NN to_TO EtOH_NNP co-administered_JJ with_IN SY_NNP
        have_VBP a_DT fully_RB intact_JJ corpus_NN callosum_NN ,_, yet_RB display_NN a_DT
        right-paw_JJ preference_NN ._. Why_WRB SY_NNP would_MD have_VB any_DT impact_NN on_IN
        laterality_NN that_WDT is_VBZ distinct_JJ from_IN EtOH_NNP exposure_NN is_VBZ puzzling_JJ ._.
        There_EX is_VBZ a_DT possible_JJ explanation_NN in_IN light_NN of_IN the_DT
        gender-specific_JJ differences_NNS observed_VBD in_IN callosal_NN size_NN [_NN 24_CD
        ]_NN coupled_VBN with_IN the_DT fact_NN that_DT prenatal_NN exposure_NN to_TO EtOH_NNP
        causes_NNS feminization_NN of_IN male_JJ rats_NNS and_CC defeminization_NN of_IN
        female_JJ rats_NNS [_NN 12_CD 25_CD 26_CD ]_NN ._. There_EX is_VBZ a_DT hormonal_NN influence_NN on_IN
        the_DT developing_VBG commissural_NN pathway_NN that_WDT could_MD be_VB disrupted_VBN
        by_IN a_DT number_NN of_IN EtOH-induced_NNP aberrations_NNS in_IN hormone_NN
        activity_NN ,_, such_JJ as_IN the_DT diminished_VBN perinatal_NN surge_NN of_IN
        testosterone_NN observed_VBD in_IN EtOH-exposed_NNP male_JJ fetal_JJ rats_NNS [_NN 27_CD
        ]_NN ._. The_DT EtOH-induced_NNP attenuation_NN of_IN the_DT testosterone_NN surge_NN
        eliminated_VBD the_DT normal_JJ sex_NN difference_NN in_IN rat_NN callosal_NN size_NN ._.
        In_IN a_DT previous_JJ study_NN we_PRP observed_VBD that_IN the_DT coadministration_NN
        of_IN SY_NNP with_IN EtOH_NNP to_TO pregnant_JJ dams_NNS prevented_VBD the_DT EtOH-induced_NNP
        deficits_NNS in_IN social_JJ recognition_NN observed_VBD in_IN the_DT EtOH-exposed_NNP
        offspring_NN [_NN 20_CD ]_NN ._. Social_NNP memory_NN in_IN rats_NNS is_VBZ a_DT sexually_RB
        dimorphic_JJ behavior_NN that_WDT requires_VBZ adequate_JJ levels_NNS of_IN
        perinatal_NN and_CC neonatal_NN androgen_NN activity_NN ._. In_IN utero_NN exposure_NN
        to_TO EtOH_NNP reduces_VBZ testosterone_NN levels_NNS as_RB well_RB as_IN maternal_NN
        levels_NNS of_IN estrogen_NN ;_: consequently_RB there_EX is_VBZ a_DT reduction_NN in_IN
        P_NN 450_CD -_: aromatase_NN activity_NN [_NN 28_CD 29_CD ]_NN ._. This_DT then_JJ results_VBZ in_IN a_DT
        reduction_NN in_IN estrogen_NN and_CC estrogen_NN receptor_NN activation_NN ._.
        Estrogen_NNP receptor_NN activity_NN is_VBZ necessary_JJ for_IN the_DT expression_NN
        of_IN androgen-driven_JJ behavior_NN in_IN rodents_NNS [_NN 30_CD 27_CD ]_NN ._. In_IN
        addition_NN to_TO behavior_NN ,_, estrogen_NN also_RB affects_VBZ neurogenesis_NNS ,_,
        synaptogenesis_NNS ,_, and_CC synaptic_JJ modifications_NNS [_NN 31_CD ]_NN ._. Our_PRP$
        subjects_NNS were_VBD the_DT female_JJ offspring_NN of_IN the_DT various_JJ treatment_NN
        groups_NNS ._. As_IN previously_RB confirmed_VBD [_NN 32_CD ]_NN ,_, the_DT rat_NN 's_POS corpus_NN
        callosum_NN (_( CC_NNP )_) is_VBZ a_DT sexually_RB dimorphic_JJ structure_NN with_IN the_DT
        larger_JJR CC_NNP observed_VBD in_IN male_JJ rats_NNS ._. Fitch_NNP and_CC colleagues_NNS [_NN 32_CD
        ]_NN also_RB determined_VBD that_IN the_DT feminization_NN (_( reduction_NN in_IN size_NN
        as_IN compared_VBN to_TO the_DT CC_NNP of_IN male_JJ rats_NNS )_) of_IN the_DT female_JJ CC_NNP only_RB
        occurs_VBZ if_IN the_DT ovaries_NNS are_VBP intact_JJ and_CC the_DT CC_NNP is_VBZ exposed_VBN to_TO
        estrogen_NN ._. Recently_RB ,_, Bimonte_NNP et_CC al_NN ._. [_NN 33_CD ]_NN established_VBN that_DT
        neonatal_NN exposure_NN to_TO estrogen_NN is_VBZ essential_JJ to_TO
        feminine-specific_JJ brain_NN organization_NN to_TO the_DT extent_NN that_IN the_DT
        brain_NN can_MD respond_VB appropriately_RB to_TO the_DT organizing_VBG effects_NNS
        of_IN subsequent_JJ estrogen_NN exposure_NN ._. Experimental_NNP rats_NNS were_VBD
        administered_VBN an_DT estrogen_NN receptor_NN blocker_NN ,_, and_CC later_RB at_IN
        postnatal_NN day_NN 70_CD these_DT rats_NNS responded_VBD to_TO estrogen_NN
        administration_NN with_IN an_DT increase_NN in_IN CC_NNP size_NN ;_: an_DT effect_NN
        opposite_NN of_IN what_WP would_MD be_VB expected_VBN ._. Dehmlow_NNP et_CC al_NN ._. [_NN 17_CD ]_NN
        have_VBP established_VBN that_DT silymarin_NN can_MD compete_VB with_IN estradiol_NN
        at_IN estradiol_NN receptor_NN binding_JJ sites_NNS [_NN 17_CD ]_NN ._. Therefore_RB ,_, it_PRP
        is_VBZ possible_JJ that_IN the_DT ameliorative_JJ effects_NNS of_IN SY_NNP observed_VBD in_IN
        the_DT present_JJ study_NN can_MD be_VB attributed_VBN to_TO estrogen_NN receptor_NN
        activation_NN at_IN developmentally_RB appropriate_JJ times_NNS ._.
      
      
        Conclusions_NNP
        Because_IN callosal_NN development_NN was_VBD complete_JJ in_IN rats_NNS
        exposed_VBN to_TO the_DT co-administration_JJ of_IN SY_NNP with_IN EtOH_NNP ,_, it_PRP
        appears_VBZ that_IN SY_NNP conferred_VBD some_DT ameliorative_JJ effects_NNS upon_IN
        the_DT corpus_NN callosum_NN developmental_NN process_NN ._. Without_IN the_DT SY_NNP ,_,
        EtOH-exposed_NNP pups_NNS clearly_RB displayed_VBN EtOH-induced_NNP disruption_NN
        to_TO normal_JJ callosal_NN development_NN ._. Even_RB though_IN the_DT mechanism_NN
        for_IN the_DT protective_JJ action_NN of_IN SY_NNP is_VBZ not_RB clearly_RB understood_VBN ,_,
        our_PRP$ consistent_JJ findings_NNS of_IN fetoprotectivity_NN in_IN the_DT presence_NN
        of_IN in_IN utero_NN EtOH_NNP exposure_NN merit_NN further_JJ exploration_NN ._.
      
      
        Competing_VBG interests_NNS
        None_NN declared_VBD
      
      
        Author_NN 's_POS contributions_NNS
        Author_NN 1_CD NM_NNP performed_VBD all_DT of_IN the_DT neuroanatomical_JJ
        assessments_NNS in_IN the_DT study_NN and_CC participated_VBD in_IN the_DT design_NN of_IN
        the_DT study_NN ._.
        Author_NN 2_CD LL_NNP Participated_NNP in_IN the_DT design_NN of_IN the_DT study_NN ,_, the_DT
        statistical_JJ analysis_NN ,_, and_CC drafted_VBD the_DT manuscript_NN ._.
        Author_NN 3_CD RM_NNP maintained_VBD the_DT experimental_JJ protocol_NN
        throughout_IN the_DT experiment_NN and_CC performed_VBD a_DT portion_NN of_IN the_DT
        laterality_NN assessments_NNS ._.
      
    
  
